ProCE Banner Activity

CE / CME

Expert Insights in Selecting Therapy for Chronic Hepatitis B

Multimedia
In this activity, Tram T. Tran, MD, presents a series of topical case studies featuring patients with chronic hepatitis B, and discusses how our expert faculty chose to manage them.

Pharmacists : 0.75 contact {hour} ({0.075} CEUs)

Physicians : maximum of 0.75 AMA PRA Category 1 {Credit}

Released: December 15, 2017

Expiration: December 14, 2018

No longer available for credit.

Share

Faculty

Tram T. Tran

Tram T. Tran, MD

Medical Director of Liver Transplant
Comprehensive Transplant Center
Cedars Sinai Medical Center
Associate Professor of Medicine
Division of Gastroenterology
Geffen UCLA School of Medicine
Los Angeles, California

Provided by

Jointly provided by Postgraduate Institute for Medicine and Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead

Target Audience

This program is intended for physicians, registered nurses, pharmacists, and other healthcare providers who care for patients with chronic hepatitis B.

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Apply the latest treatment guidelines when determining timing of treatment for patients with chronic hepatitis B
  • Integrate recently approved HBV therapies into patient management strategies
  • Select appropriate treatment for HBeAg-positive and HBeAg-negative patients with chronic hepatitis B based on individual patient factors

Faculty Disclosure

Primary Author

Tram T. Tran, MD

Medical Director of Liver Transplant
Comprehensive Transplant Center
Cedars Sinai Medical Center
Associate Professor of Medicine
Division of Gastroenterology
Geffen UCLA School of Medicine
Los Angeles, California

Tram T. Tran, MD, has disclosed that that she has received consulting fees, fees for non-CME/CE services, and funds for research support from Bristol-Myers Squibb and Gilead Sciences.

Staff Disclosure

Staff

Megan Cartwright, PhD

Senior Clinical Editor

Megan Cartwright, PhD, has no real or apparent conflicts of interest to report.

Anna Poppa,

Managing Editor, HIV
Clinical Care Options, LLC

Anna Poppa has no real or apparent conflicts of interest to report.

Jenny Schulz, PhD

Associate Managing Editor, Hepatitis
Clinical Care Options, LLC

Jenny Schulz, PhD, has no real or apparent conflicts of interest to report.

Instructions for Credit

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Clinical Care Options, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement

Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

This educational activity for 0.8 contact hour is provided by Postgraduate Institute for Medicine.

Accreditation Statement

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Credit Designation

Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hour (0.075 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - JA4008162-9999-18-226-H01-P.

Type of Activity: Knowledge

 

Additional Information

Participation in this self-study activity should be completed in approximately 0.75 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from December 15, 2017, through December 14, 2018:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Program Medium

This program has been made available online.


Goal


The goal of this activity is to improve clinicians’ competence in objectively evaluating the differences and similarities among available HBV agents and in selecting optimal therapy for each individual patient.